{"id":"W3206695526","doi":"10.1016/j.jns.2021.118339","title":"Efficacy and safety of eculizumab in patients with treatment-refractory anti-acetylcholine receptor antibody-positive generalised myasthenia gravis previously treated with rituximab","year":2021,"lang":"en","type":"article","venue":"Journal of the Neurological Sciences","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Alberta","funders":"Alexion Pharmaceuticals","keywords":"Eculizumab; Rituximab; Refractory (planetary science); Myasthenia gravis; Medicine; Acetylcholine receptor; Internal medicine; Phases of clinical research; Antibody; Immunology; Chemotherapy; Receptor; Complement system; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007927246,0.0002966277,0.001098074,0.0002928433,0.0003031505,0.0005117608,0.0002357867,0.0005757965,0.0007719473],"category_scores_gemma":[0.002052571,0.0001634867,0.0007052362,0.0002516441,0.0003195647,0.0004556196,0.0001416414,0.0009759645,0.0001734386],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004739056,"about_ca_system_score_gemma":0.0002531226,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005015023,"about_ca_topic_score_gemma":0.0007929814,"domain_scores_codex":[0.9996371,0.0001349987,0.00004883862,0.00005203149,0.00005110166,0.00007588695],"domain_scores_gemma":[0.9993861,0.0002589501,0.0001394996,0.00003931915,0.00003699378,0.0001391292],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.2994859,0.005331412,0.2609943,0.001216591,0.004432063,0.005685253,0.0008835653,0.003816098,0.04962125,0.0003736013,0.002057699,0.3661023],"study_design_scores_gemma":[0.04425743,0.1408931,0.7819076,0.0003474523,0.004638802,0.008292138,0.0003257426,0.005001317,0.007897942,0.000369921,0.005970251,0.00009831083],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9917652,0.007101126,0.00008676288,0.0001576289,0.00002631773,0.00002117189,0.00006466438,0.000009982112,0.0007670079],"genre_scores_gemma":[0.9988909,0.0006724799,0.00004552846,0.0001188444,0.00003670427,0.00001341853,0.00009637271,0.000001767601,0.0001239434],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001098074,"threshold_uncertainty_score":0.004192412,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01178255384138181,"score_gpt":0.2576730317253048,"score_spread":0.245890477883923,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}